TRAVERE THERAPEUTICS INC. - COMMON STOCK
19.73
14-March-25 16:45:00
15 minutes delayed
Stocks
+0.60
+3.14%
Today's range
18.86 - 19.87
ISIN
N/A
Source
NASDAQ
-
25 Aug 2022 16:30:00 By Nasdaq GlobeNewswire
-
22 Aug 2022 07:00:00 By Nasdaq GlobeNewswire
-
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11 Aug 2022 17:00:00 By Nasdaq GlobeNewswire
-
Travere Therapeutics Reports Second Quarter 2022 Financial Results
04 Aug 2022 07:00:02 By Nasdaq GlobeNewswire
-
Travere Therapeutics Provides Regulatory Updates on its Development Programs
03 Aug 2022 16:05:01 By Nasdaq GlobeNewswire
-
Travere Therapeutics to Report Second Quarter 2022 Financial Results
28 Jul 2022 16:30:00 By Nasdaq GlobeNewswire
-
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12 Jul 2022 17:00:00 By Nasdaq GlobeNewswire
-
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
14 Jun 2022 17:00:00 By Nasdaq GlobeNewswire
-
Travere Therapeutics to Present at the 2022 Jefferies Healthcare Conference
02 Jun 2022 16:30:00 By Nasdaq GlobeNewswire
-
Travere Therapeutics Announces Presentations of Abstracts at the 59th ERA Congress
17 May 2022 16:30:00 By Nasdaq GlobeNewswire
-
16 May 2022 07:00:01 By Nasdaq GlobeNewswire
-
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11 May 2022 17:00:00 By Nasdaq GlobeNewswire
-
Travere Therapeutics Reports First Quarter 2022 Financial Results
05 May 2022 16:01:01 By Nasdaq GlobeNewswire
-
Travere Therapeutics to Present at the BofA Securities 2022 Healthcare Conference
03 May 2022 16:30:00 By Nasdaq GlobeNewswire
-
Travere Therapeutics to Report First Quarter 2022 Financial Results
28 Apr 2022 16:30:00 By Nasdaq GlobeNewswire
-
Travere Therapeutics Announces Plan for Chief Financial Officer Transition
20 Apr 2022 16:30:00 By Nasdaq GlobeNewswire
-
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12 Apr 2022 17:00:00 By Nasdaq GlobeNewswire
-
06 Apr 2022 16:30:00 By Nasdaq GlobeNewswire
-
21 Mar 2022 07:00:01 By Nasdaq GlobeNewswire
-
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
14 Mar 2022 17:00:00 By Nasdaq GlobeNewswire